Is Banner Display?
Off
Page Content
#ffffff

Insulin resistance (IR) precedes type 2 diabetes and may vary in severity and organ-specific location, influencing body composition and diabetes risk. At the European Association for the Study of Diabetes (EASD) 2025, data from 5,509 participants (53% women, mean age 54 ± 6 years, BMI 30 ± 5 kg/m²) in the Netherlands Epidemiology of Obesity (NEO) study were analyzed to examine organ-specific IR subtypes. 

Hepatic insulin resistance index (HIRI), muscle insulin resistance index (MIRI), and disposition index (DI) were used to classify participants into eight IR subtypes. During a median follow-up of 6.6 years, 283 participants developed type 2 diabetes. Subtypes characterized by low DI and hepatic IR, with or without concomitant muscle IR, carried the highest diabetes risk (HR=19.48 [9.02–42.09] and HR=20.16 [9.32–43.60], respectively). 

These subtypes also exhibited the greatest adiposity, largest waist circumference, and highest visceral and liver fat. The findings highlight the prognostic importance of hepatic IR and beta-cell dysfunction in type 2 diabetes development and suggest targeted monitoring and early interventions for high-risk metabolic profiles.

Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Key highlights
  • Subtypes combining low disposition index with hepatic insulin resistance, with or without additional muscle insulin resistance, were associated with the highest risk of developing type 2 diabetes.
  • Participants with hepatic insulin resistance subtypes exhibited greater overall adiposity, larger waist circumference, and increased visceral and liver fat compared to other insulin resistance subtypes.
  • Identifying organ-specific insulin resistance patterns can improve risk stratification and potentially guide early preventive interventions for type 2 diabetes.
Source

Van der Velde JHP, Wopereis S, Oosterman JE, et al. Differences in body fat distribution and risk of type 2 diabetes between subtypes of insulin resistance. Presented at: 61st EASD Annual Meeting of the European Association for the Study of Diabetes; September 15-19, 2025; Vienna, Austria. Diabetologia. 2025:244. https://link.springer.com/article/10.1007/s00125-025-06497-1#Sec43 

Thumbnail
Hepatic Insulin Resistance and Low Beta-Cell Function Mark Highest Risk Subtypes for Type 2 Diabetes
Schedule Date & Time
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description

Differential body fat distribution and diabetes risk identified across organ-specific insulin resistance subtypes in a population cohort at EASD 2025.
 

Release Date
Is Paid
0